Science Explorer Back to mapMap
Discussion
Researcher · CureVac (Germany) · Germany

Oliver Schönborn‐Kellenberger

Oliver Schönborn‐Kellenberger publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Multiple Myeloma Research and Treatments, SARS-CoV-2 and COVID-19 Research and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-5266-7881 OpenAlex
World rank
#1,664,842
of 7,710,434 ranked researchers
Rank in Germany
#82,079
of 364,343
Works
66
Citations
1.1k
Citations per work
16.4
h-index
13
i10-index 14Top 44% in Oncology
Oliver Schönborn‐Kellenberger

What does Oliver Schönborn‐Kellenberger research?

Oliver Schönborn‐Kellenberger's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (11%).

Everything else: 26 works · 39.5% of their workHealth Sciences: 24 works · 36.8% of their workMedicine: 24 works · 36.8% of their workOncology: 9 works · 14.0% of their workInfectious Diseases: 6 works · 9.6% of their workHematology: 6 works · 8.8% of their workSurgery: 3 works · 4.4% of their workLife Sciences: 16 works · 23.7% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 12.3% of their workMolecular Biology: 8 works · 12.3% of their workImmunology and Microbiology: 8 works · 11.4% of their workImmunology: 8 works · 11.4% of their workTHEIR WORKOliverSchönborn‐Kellenberger66works
Life Sciences24%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2639.5%
    1. Medicine2436.8%
    1. Biochemistry, Genetics and Molecular Biology812.3%
    2. Immunology and Microbiology811.4%
  1. 1Oncology14% of their works
  2. 2Molecular Biology12% of their works
  3. 3Immunology11% of their works
  4. 4Infectious Diseases10% of their works
  5. 5Hematology9% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Oliver Schönborn‐Kellenberger's research?

The keywords of their largest research topics: Coronavirus, Vaccine, Diagnosis Criteria, International Myeloma Working Group, SARS-CoV-2, spike protein, Bone Mineral Density and Fractures.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Coronavirus102 topics
  2. Vaccine102 topics
  3. Diagnosis Criteria61 topic
  4. International Myeloma Working Group61 topic
  5. SARS-CoV-261 topic
  6. spike protein61 topic
  7. Bone Mineral Density51 topic
  8. Fractures51 topic
  9. Immune Checkpoint Blockade51 topic
  10. PD-1 and PD-L151 topic
  11. Bisphosphonates41 topic
  12. Circovirus41 topic
  13. Immunotoxin41 topic
  14. Osteonecrosis of the Jaw41 topic
  15. Porcine Reproductive and Respiratory Syndrome Virus41 topic
  16. RNA Interference41 topic
  17. Ricin Poisoning41 topic
  18. siRNA Delivery41 topic

Where does Oliver Schönborn‐Kellenberger work?

Oliver Schönborn‐Kellenberger's main affiliation in the publication record is CureVac (Germany), Germany.

How many publications and citations does Oliver Schönborn‐Kellenberger have?

OpenAlex counts 66 works and 1,084 citations for Oliver Schönborn‐Kellenberger, an h-index of 13, ranking #1,664,842 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Oliver Schönborn‐Kellenberger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.